Matthew D. Silverman

Cooley advised Adaptive Phage Therapeutics, a US-based, privately held, clinical-stage biotechnology company pioneering the development of phage-based therapies to combat bacterial infections, on its definitive merger agreement with BiomX, a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria.

Cooley advised Tourmaline Bio, a late-stage clinical biotechnology company, on its merger agreement with Talaris Therapeutics, including a concurrent private placement.

Cooley advised SoundHound AI, a leader in voice artificial intelligence, in the closing of a new $125 million loan facility from Atlas Credit Partners.

Cooley advised Justin Bieber in a $200 million deal to sell his music rights to Blackstone-backed Hipgnosis Songs Capital.

Cooley advised Apollo Endosurgery, a medical device company, on its agreement to be acquired by Boston Scientific in an all-cash transaction with an enterprise value of approximately $615 million.